Biomedical Device Consultants and Laboratories (BDC Laboratories) announced today that its VDT-3600i Accelerated Wear Testing (AWT) system for heart valves allows evaluation of chronic wear in valve leaflets in a predictable, controlled, and reproducible manner. The press release states that the AWT system demonstrates how a device may perform throughout its chronic use in vivo to support research and development efforts, for example, with respect to the emerging transcatheter aortic valve implantation and minimally invasive mitral valve replacement fields.
According to the press release, positive clinical outcomes continue to be reported by researchers studying transcatheter aortic valve implantation using the AWT system. BDC Laboratories states that it provides innovative and advanced product offerings to support medical device companies in evaluating their next-generation implants.
BDC Laboratories’ press release is available here.